High Flow Nasal Cannula Market Value Surpass USD 15,926.4 million by 2030

The global High Flow Nasal Cannula Market size is estimated to generate revenues of more than USD 15,926.4 million by 2030, growing at a CAGR of around 11.3% from 2021 to 2030

The report covers SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. The report offers an analysis of the global high flow nasal cannula Market for the period 2016 to 2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.

The wide application portfolio of high flow nasal cannula market is one of factors driving the growth of market worldwide. The global market is moderately competitive with a blend of global and regional players. The markets key players invest significantly in R and D to enhance their offerings. The entire ecosystem is composed of multiple participants. Every participant of the ecosystem is an equal contributor to the growth of global market.

Why should you invest in this report?

If you are aiming to enter the global high flow nasal cannula Market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for high flow nasal cannula are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly. Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Report Structure:

• pertinent market numbers of the global high flow nasal cannula market along with the CAGR for the forecast period 2021-2030
• detailed definitions of different types of high flow nasal cannula, which gives clarity about what this market is all about and also defines the scope of this report
• macroeconomic factors influencing the global high flow nasal cannula market, along with market opportunity analysis
• key trends likely to impact the global high flow nasal cannula market
• PESTLE analysis of all the regions as per the market taxonomy
• Porter’s Five Force Analysis of all the regions as given in the market taxonomy

Global market analysis and forecast:

• the global high flow nasal cannula market analysis and forecast by product type, by application, by region and others
• key market metrics such as the BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the global high flow nasal cannula market

Regional market analysis and forecast:

• Regional high flow nasal cannula market analysis and forecast
• Regional market dynamics including the drivers, restraints and trends applicable across different regions in the high flow nasal cannula market along with factors encouraging the growth of this market as well as the factors hampering the growth of this market
• Regional trends – both long term and short term

View Full Report@ https://www.precedenceresearch.com/high-flow-nasal-cannula-market

Competitive landscape:

• the competitive landscape of this global report
• information on the various leading companies in the global market
• a dashboard view of the key companies operating in the global market along with their important information and broad strategy adopted to stay as leaders in the global market
• key company profiles along with important information such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis

Some of the prominent players in high flow nasal cannula market include:

• Armstrong Medical Ltd
• Salter Labs Inc
• ResMed, Inc.
• Teleflex Inc
• Vapotherm Inc.
• Becton Dickinson, and Company
• Smiths Medical
• Flexicare Medical Ltd
• Teijin Pharma Limited
• TNI Medical AG
• Fisher & Paykel Healthcare Limited
• Hamilton Medical AG

Market Segmentation:

By Product Type

• Single heated tube
• Nasal cannula
• Active humidifier
• Air blender

By Application

• Acute Respiratory Failure
• Chronic Obstructive Pulmonary Disease
• Acute Heart Failure
• Others

By End-user

• Hospitals and clinics
• Ambulatory care centers
• Long-term care centers
• Others

By Sales Channel

• Direct Channel
• Distribution Channel

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Research Methodology

In this report, historical data, primary responses and public domain data has been thoroughly analyzed to infer the market size. Revenue of companies operating in the global market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to determine the market size for the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and extensively scrutinized using advanced tools to garner quantitative and qualitative insights into the global high flow nasal cannula.

TABLE OF CONTENT

Chapter 1.    Introduction

1.1.    Research Objective
1.2.    Scope of the Study
1.3.    Definition

Chapter 2.    Research Methodology

2.1.    Research Approach
2.2.    Data Product Types
2.3.    Assumptions& Limitations

Chapter 3.    Executive Summary

3.1.    Market Snapshot

Chapter 4.    High Flow Nasal Cannula Market Variables and Scope 

4.1.    Introduction
4.2.    Market Classification and Scope

Chapter 5.    COVID 19 Impact on High Flow Nasal Cannula Market

5.1.    Covid-19: High Flow Nasal Cannula Industry Impact
5.2.    High Flow Nasal Cannula Business Impact Assessment: Covid-19
5.2.1.    Services Challenges/Disruption
5.2.2.    Market Trends and High Flow Nasal Cannula Opportunities in the COVID-19 Landscape for Major Markets
5.3.    Strategic Measures against Covid-19
5.3.1.    Government Support and Initiative to Combat Covid-19 
5.3.2.    Proposal for High Flow Nasal Cannula Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6.    High Flow Nasal Cannula Market Dynamics Analysis and Trends

6.1.    Market Dynamics
6.1.1.    Market Drivers
6.1.1.1.    Ever-increasing number of respiratory disorders
6.1.1.2.    Low cost of high-flow nasal cannula compared to low-flow oxygen delivery systems
6.1.2.    Market Restraints
6.1.2.1.    Low rate of adoption of modern healthcare applications in developing countries
6.1.3.    Market Opportunities
6.1.3.1.    Increasing popularity and uptake of heated humidified high-flow nasal cannulas

Chapter 7.    Global High Flow Nasal Cannula Market: Competitive Landscape

7.1.1.    Company Market Share/Positioning Analysis
7.1.1.1.    High Flow Nasal Cannula Market Revenue by Market Players (2017 - 2020)
7.1.1.2.    High Flow Nasal Cannula Market Revenue Market Share by Market Players (2017 - 2020)
7.1.2.    Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1.    Product Portfolio, Expansion, Geographic Expansion, Product Innovation
7.1.2.2.    Merger and Acquisition, Collaboration and Partnerships
7.1.3.    Market Players Landscape
7.1.3.1.    List of Suppliers
7.1.3.2.    List of End user

Chapter 8.    Global High Flow Nasal Cannula Market, By Product Type

8.1.    High Flow Nasal Cannula Market, by Product Type, 2017-2030
8.1.1.    Single Heated Tube
8.1.1.1.    Market Revenue and Forecast (2017-2030)
8.1.2.    Nasal cannula
8.1.2.1.    Market Revenue and Forecast (2017-2030)
8.1.3.    Active humidifier
8.1.3.1.    Market Revenue and Forecast (2017-2030)
8.1.4.    Air blender 
8.1.4.1.    Market Revenue and Forecast (2017-2030)

Chapter 9.    Global High Flow Nasal Cannula Market, By End-user

9.1.    High Flow Nasal Cannula Market, by End-user, 2017-2030
9.1.1.    Hospitals and clinics 
9.1.1.1.    Market Revenue and Forecast (2017-2030)
9.1.2.    Ambulatory care centers 
9.1.2.1.    Market Revenue and Forecast (2017-2030)
9.1.3.    Long-term care centers    
9.1.3.1.    Market Revenue and Forecast (2017-2030)
9.1.4.    Others   
9.1.4.1.    Market Revenue and Forecast (2017-2030)

Chapter 10.    Global High Flow Nasal Cannula Market, By Application

10.1.    High Flow Nasal Cannula Market, by Application, 2017-2030
10.1.1.    Acute Respiratory Disorder 
10.1.1.1.    Market Revenue and Forecast (2017-2030)
10.1.2.    Chronic Respiratory Disorder 
10.1.2.1.    Market Revenue and Forecast (2017-2030)
10.1.3.    Acute Heart Failures 
10.1.3.1.    Market Revenue and Forecast (2017-2030)
10.1.4.    Others 
10.1.4.1.    Market Revenue and Forecast (2017-2030)

Chapter 11.    Global High Flow Nasal Cannula Market, By Sales Channel 

11.1.    High Flow Nasal Cannula Market, by Sales Channel, 2017-2030
11.1.1.    Direct Channel
11.1.1.1.    Market Revenue and Forecast (2017-2030)
11.1.2.    Distribution Channel
11.1.2.1.    Market Revenue and Forecast (2017-2030)

Chapter 12.    Global High Flow Nasal Cannula Market, Regional Estimates and Trend Forecast

12.1.    North America
12.1.1.    Market Revenue Forecast by Product Type(2017-2030)
12.1.2.    Market Revenue Forecast by End-user (2017-2030)
12.1.3.    Market Revenue Forecast by Application (2017-2030)
12.1.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.1.5.    U.S
12.1.5.1.    Market Revenue Forecast (2017-2030)
12.1.6.    Canada 
12.1.6.1.    Market Revenue Forecast (2017-2030)
12.2.    Europe
12.2.1.    Market Revenue Forecast by Product Type (2017-2030)
12.2.2.    Market Revenue Forecast by End-user (2017-2030)
12.2.3.    Market Revenue Forecast by Application (2017-2030)
12.2.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.2.5.    UK
12.2.5.1.    Market Revenue Forecast (2017-2030)
12.2.6.    Germany
12.2.6.1.    Market Revenue Forecast (2017-2030)
12.2.7.    France
12.2.7.1.    Market Revenue Forecast (2017-2030)
12.2.8.    Rest of EU
12.2.8.1.    Market Revenue Forecast (2017-2030)
12.3.    Asia Pacific (APAC)
12.3.1.    Market Revenue Forecast by Product Type (2017-2030)
12.3.2.    Market Revenue Forecast by End-user (2017-2030)
12.3.3.    Market Revenue Forecast by Application (2017-2030)
12.3.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.3.5.    China
12.3.5.1.    Market Revenue Forecast (2017-2030)
12.3.6.    India
12.3.6.1.    Market Revenue Forecast (2017-2030)
12.3.7.    Japan 
12.3.7.1.    Market Revenue Forecast (2017-2030)
12.3.8.    Rest of APAC
12.3.8.1.    Market Revenue Forecast (2017-2030)
12.4.    LATAM
12.4.1.    Market Revenue Forecast by Product Type (2017-2030)
12.4.2.    Market Revenue Forecast by End-user (2017-2030)
12.4.3.    Market Revenue Forecast by Application (2017-2030)
12.4.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.4.5.    Brazil
12.4.5.1.    Market Revenue Forecast (2017-2030)
12.4.6.    Rest of LATAM
12.4.6.1.    Market Revenue Forecast (2017-2030)
12.5.    Middle East and Africa (MEA)
12.5.1.    Market Revenue Forecast by Product Type (2017-2030)
12.5.2.    Market Revenue Forecast by End-user (2017-2030)
12.5.3.    Market Revenue Forecast by Application (2017-2030)
12.5.4.    Market Revenue Forecast by Sales Channel (2017-2030)
12.5.5.    GCC
12.5.5.1.    Market Revenue Forecast (2017-2030)
12.5.6.    North Africa
12.5.6.1.    Market Revenue Forecast (2017-2030)
12.5.7.    South Africa
12.5.7.1.    Market Revenue Forecast (2017-2030)
12.5.8.    Rest of MEA
12.5.8.1.    Market Revenue Forecast (2017-2030)

Chapter 13.    Company Profiles

13.1.    Armstrong Medical Ltd
13.1.1.    Company Overview, Business Information, Regional Presence
13.1.2.    Product Portfolio, Analysis
13.1.2.1.    Product Details, Specification, Application
13.1.3.    Revenue, Price, and Gross Margin (2017-2020)
13.1.4.    Recent Developments and Strategies
13.2.    Becton Dickinson, and Company
13.2.1.    Company Overview, Business Information, Regional Presence
13.2.2.    Product Portfolio, Analysis
13.2.2.1.    Product Details, Specification, Application
13.2.3.    Revenue, Price, and Gross Margin (2017-2020)
13.2.4.    Recent Developments and Strategies
13.3.    Fisher & Paykel Healthcare Limited
13.3.1.    Company Overview, Business Information, Regional Presence
13.3.2.    Product Portfolio, Analysis
13.3.2.1.    Product Details, Specification, Application
13.3.3.    Revenue, Price, and Gross Margin (2017-2020)
13.3.4.    Recent Developments and Strategies
13.4.    Flexicare Medical Ltd
13.4.1.    Company Overview, Business Information, Regional Presence
13.4.2.    Product Portfolio, Analysis
13.4.2.1.    Product Details, Specification, Application
13.4.3.    Revenue, Price, and Gross Margin (2017-2020)
13.4.4.    Recent Developments and Strategies
13.5.    Hamilton Medical AG
13.5.1.    Company Overview, Business Information, Regional Presence
13.5.2.    Product Portfolio, Analysis
13.5.2.1.    Product Details, Specification, Application
13.5.3.    Revenue, Price, and Gross Margin (2017-2020)
13.5.4.    Recent Developments and Strategies
13.6.    ResMed, Inc.
13.6.1.    Company Overview, Business Information, Regional Presence
13.6.2.    Product Portfolio, Analysis
13.6.2.1.    Product Details, Specification, Application
13.6.3.    Revenue, Price, and Gross Margin (2017-2020)
13.6.4.    Recent Developments and Strategies
13.7.    Salter Labs Inc
13.7.1.    Company Overview, Business Information, Regional Presence
13.7.2.    Product Portfolio, Analysis
13.7.2.1.    Product Details, Specification, Application
13.7.3.    Revenue, Price, and Gross Margin (2017-2020)
13.7.4.    Recent Developments and Strategies
13.8.    Smiths Medical
13.8.1.    Company Overview, Business Information, Regional Presence
13.8.2.    Product Portfolio, Analysis
13.8.2.1.    Product Details, Specification, Application
13.8.3.    Revenue, Price, and Gross Margin (2017-2020)
13.8.4.    Recent Developments and Strategies
13.9.    Teijin Pharma Limited.
13.9.1.    Company Overview, Business Information, Regional Presence
13.9.2.    Product Portfolio, Analysis
13.9.2.1.    Product Details, Specification, Application
13.9.3.    Revenue, Price, and Gross Margin (2017-2020)
13.9.4.    Recent Developments and Strategies
13.10.    Teleflex Inc
13.10.1.    Company Overview, Business Information, Regional Presence
13.10.2.    Product Portfolio, Analysis
13.10.2.1.    Product Details, Specification, Application
13.10.3.    Revenue, Price, and Gross Margin (2017-2020)
13.10.4.    Recent Developments and Strategies
13.11.    TNI Medical AG
13.11.1.    Company Overview, Business Information, Regional Presence
13.11.2.    Product Portfolio, Analysis
13.11.2.1.    Product Details, Specification, Application
13.11.3.    Revenue, Price, and Gross Margin (2017-2020)
13.11.4.    Recent Developments and Strategies
13.12.    Vapotherm Inc.
13.12.1.    Company Overview, Business Information, Regional Presence
13.12.2.    Product Portfolio, Analysis
13.12.2.1.    Product Details, Specification, Application
13.12.3.    Revenue, Price, and Gross Margin (2017-2020)
13.12.4.    Recent Developments and Strategies

Chapter 14.    Appendix

14.1.    About Us
14.2.    Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333      

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Blog: http://www.marketstatsnews.com/

Follow us on LinkedIn | Twitter | Facebook